Trump Considers Reclassifying Marijuana to Less Dangerous Status

President Donald Trump is contemplating reclassifying marijuana from a Schedule I to a Schedule III controlled substance, a move that could significantly alter federal cannabis policy.

 

Addressing reporters on Monday, Trump acknowledged the complexity of the issue, noting concerns about marijuana's impact on children while also recognizing its potential medical benefits.

 

He stated that discussions are in the early stages, with no immediate decision expected.

 

Reclassifying marijuana to Schedule III would acknowledge its accepted medical use and lower its abuse potential compared to substances like heroin and LSD.

 

This change could reduce legal penalties for possession and facilitate research into cannabis-based treatments.

 

Such a shift aligns with growing public support for marijuana reform.

 

According to recent polls, approximately 68% of Americans favor legalization for medical or recreational use.

 

Currently, 40 states and the District of Columbia permit medical marijuana, while 24 states have legalized recreational use.

 

Trump's consideration follows significant lobbying efforts from the cannabis industry.

 

Reports indicate that marijuana companies have contributed millions to his political organizations, aiming to influence federal policy.

 

However, the proposal has sparked debate within conservative circles.

 

Some supporters express concern that reclassification could undermine traditional values and promote a "pothead" culture.

 

Others argue that acknowledging marijuana's medical applications aligns with a broader health-focused agenda.

 

While reclassification would not equate to full legalization, it could ease restrictions on banking and taxation for cannabis businesses, particularly in states where marijuana is already legal.

 

As discussions continue, stakeholders from various sectors are closely monitoring potential developments.

 

Trump emphasized that any decision would be made carefully, considering both the potential benefits and the concerns associated with marijuana use.